Status:

NOT_YET_RECRUITING

An Exploratory Study of Iliac Artery Branch Stent for Internal Iliac Artery Reconstruction in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair

Lead Sponsor:

RenJi Hospital

Conditions:

Aortic Aneurysm, Abdominal

Iliac Aneurysm

Eligibility:

All Genders

18-85 years

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company in the treatment of abdominal aortic aneurysm/iliac an...

Detailed Description

This study is a prospective observational exploratory cohort study without a control group. As a single-group target value validation study, the main evaluation indicator is the primary patency rate o...

Eligibility Criteria

Inclusion

  • Patients with iliac aneurysms combined with or without abdominal aortic aneurysms and internal iliac arteries reconstructed with iliac branch stents;
  • Male or female ≥18 years old, ≤85 years old;
  • Life expectancy \> 2 years;
  • The patient signed the informed consent voluntarily and was able to comply with the treatment plan and complete the follow-up and examination as planned.

Exclusion

  • Fungal or ruptured aneurysm
  • Known complications of thoracic aortic aneurysm require interventional treatment
  • American Association of Anesthesiologists (ASA) Grade V
  • Creatinine \> 2.5mg/dL or dialysis patients
  • NYHA Grade IV heart failure
  • Intercalation, severe calcification, or anchoring area with thrombosis
  • Severe curvature or narrowing of the iliac and/or femoral arteries, resulting in difficulty in stent delivery
  • Conduct another device or drug study within 1 year of treatment
  • Systemic infection
  • Combined with connective tissue disease
  • Known history of drug use
  • Known allergies or allergies to equipment materials

Key Trial Info

Start Date :

December 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06162273

Start Date

December 1 2023

End Date

December 1 2026

Last Update

December 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Renji Hospital

Shanghai, Shanghai Municipality, China, 200127